BECLATE

This brand name is authorized in Ecuador, Hong Kong SAR China, South Africa.

Active ingredients

The drug BECLATE contains one active pharmaceutical ingredient (API):

1	Beclometasone UNII 5B307S63B2 - BECLOMETHASONE DIPROPIONATE
	Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.
	Read more about Beclometasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BECLATE Nasal spray	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA01	Beclometasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29504-12-10
HK	Department of Health Drug Office	51053, 51262, 51264
ZA	Health Products Regulatory Authority	30/21.5.1/0079, 30/21.5.1/0080, 30/21.5.1/0081, 30/21.5.1/0147, 32/13.4.1/0127, 34/21.5.1/0093, 37/21.5.1/0652, 37/21.5.1/0653, 37/21.5.1/0654, 38/21.5.1/0186